The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy von Holmström, M O, Martinenaite, E, Ahmad, S M, Met, Ö, Friese, C, Kjær, L, Riley, C H, thor Straten, P, Svane, I M, Hasselbalch, H C, Andersen, M H

Volltext

09.03 Characterization of T cell specificity and exercise-induced dynamics of soluble immunological markers before and after high-intensity aerobic exercise (INHALE) von Leuchte, K, Luu, V, Salo, S, Vinther, A, Thor Straten, P, Olofsson, G

Volltext

The antiapoptotic member of the Bcl-2 family Mcl-1 is a CTL target in cancer patients von Andersen, M H, Becker, J C, thor Straten, P

Volltext

Changes in Peripheral Blood Level of Regulatory T cells in Patients with Malignant Melanoma During Treatment with Dendritic Cell Vaccination and Low-dose IL-2 von Bjoern, J, Brimnes, M.K, Andersen, M.H, thor Straten, P, Svane, I.M

Volltext

The 1170 A-P single-nucleotide polymorphism (SNP) in the Her-2 neu protein (HER2) as a minor histocompatibility antigen (mHag) von Wenandy, L, Kollgaard, T, Letsch, A, Andersen, R S, Stather, D, Seremet, T, Svane, I M, Vindeløv, L, Andersen, M H, thor Straten, P

Volltext

Natural T-cell responses against minor histocompatibility antigen (mHag) HY following HLA-matched hematopoietic cell transplantation: what are the requirements for a 'good' mHag? von Kollgaard, T, Hadrup, S Reker, Petersen, S L, Masmas, T N, Andersen, M H, Spierings, E, Vindeløv, L, thor Straten, P

Volltext

Evidence for involvement of clonally expanded CD8 T cells in anticancer immune responses in CLL patients following nonmyeloablative conditioning and hematopoietic cell transplantat... von KOLLGAARD, T, PETERSEN, S. L, HADRUP, S. Reker, MASMAS, T. N, SEREMET, T, ANDERSEN, M. H, MADSEN, H. O, VINDELØV, L, THOR STRATEN, P

Volltext

Mcl-1 and anticancer vaccination: identification of an HLA-A2-restricted epitope von Andersen, R S, Wenandy, L, Sørensen, R B, thor Straten, P, Andersen, M H

Volltext

Identification of an HLA-A1 restricted CTL epitope from Mcl-1 von Andersen, M H, Kvistborg, P, Becker, J C, thor Straten, P

Volltext

T cell recognition of breast cancer antigens von Ramskov, S., Petersen, N Viborg, Sick Andersen, R., Straten, P Thor, Svane, I-M, Met, Ö, Hadrup, S Reker

Volltext

Functional capacity of Mcl-1-specific cytotoxic T-cells von Sørensen, R B, Nielsen, O J, thor Straten, P, Andersen, M H

Volltext

5-Azacytidine treatment sensitizes tumor cells to T-cell mediated cytotoxicity and modulates NK cells in patients with myeloid malignancies von Gang, A O, Frøsig, T M, Brimnes, M K, Lyngaa, R, Treppendahl, M B, Grønbæk, K, Dufva, I H, Straten, P thor, Hadrup, S R

Volltext

The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays von Britten, C. M., Gouttefangeas, C., Welters, M. J. P., Pawelec, G., Koch, S., Ottensmeier, C., Mander, A., Walter, S., Paschen, A., Müller-Berghaus, J., Haas, I., Mackensen, A., Køllgaard, T., thor Straten, P., Schmitt, M., Giannopoulos, K., Maier, R., Veelken, H., Bertinetti, C., Konur, A., Huber, C., Stevanović, S., Wölfel, T., van der Burg, S. H.

Volltext

Concurrent disruption of cell cycle associated genes in mantle cell lymphoma : a genotypic and phenotypic study of cyclin D1, p16, p15, p53 and pRb von GRØNBAEK, K, NEDERGAARD, T, ANDERSEN, M. K, THOR STRATEN, P, GULDBERG, P, MØLLER, P, ZEUTHEN, J, EBBE HANSEN, N, HOU-JENSEN, K, RALFKIAER, E

Volltext

A case of lymphoblastoid natural killer (NK)‐cell lymphoma: association with the NK‐cell receptor complex CD94/NKG2 
and TP53 intragenic deletion von Knudsen, H., Grønbæk, K., Thor Straten, P., Gisselø, C., Johansen, P., Timshel, S., Bergmann, O.J., Hansen, N.E., Ralfkiær, E.

Volltext

Detection and Characterization of αβ-T-Cell Clonality by Denaturing Gradient Gel Electrophoresis (DGGE) von Straten, P. thor, Barfoed, A, Seremet, T, Saeterdal, I, Zeuthen, J, Guldberg, P

Volltext

P29. T-cell responses to oncogenic Merkel cell polyomavirus proteins distinguish Merkel cell carcinoma patients from healthy donors von Lyngaa, L, Pedersen, NW, Schrama, D, Thrue, CA, Ibrani, D, Met, O, thor Straten, P, Nghiem, P, Becker, JC, Hadrup, SR

Volltext

P75. Genetic engineering of T cells for increased homing to the tumor site von Idorn, M, Andersen, GH, Larsen, HL, van den Berg, JH, Met, Ö, thor Straten, P

Volltext

Safety, immunogenicity, and clinical response of a survivin-based peptide vaccine in therapy-resistant advanced cancer: Results from a phase I/II trial von Becker, J. C., Wobser, M., Hofmeister, V., Bauer, B., Broecker, E. B., thor Straten, P., Andersen, M. H.

Volltext

Cytotoxic T‐Lymphocyte Clones, Established by Stimulation with the HLA‐A2 Binding p5365–73 Wild Type Peptide Loaded on Dendritic Cells In Vitro, Specifically Recognize and Lyse HLA... von Barfoed, A M, Petersen, T R, Kirkin, A F, Thor Straten, P, Claesson, M H, Zeuthen, J

Volltext